Jane Street’s OnKure Therapeutics OKUR Stock Holding History

Jane Street’s Portfolio OKUR Stock Details OKUR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$111K	Buy	26,812 +7,398	+38%	+$22.8K	﹤0.01%	10586
2025 Q4	$56.3K	Buy	+19,414	New	+$58.1K	﹤0.01%	10467
2024 Q3	–	Sell	-6,204	Closed	-$93.7K	–	10593
2024 Q2	$93.7K	Buy	+6,204	New	+$105K	﹤0.01%	8752
2024 Q1	–	Sell	-7,894	Closed	-$126K	–	10244
2023 Q4	$126K	Buy	+7,894	New	+$492K	﹤0.01%	8478
2023 Q2	–	Sell	-1,974	Closed	-$118K	–	9728
2023 Q1	$118K	Buy	+1,974	New	+$71.5K	﹤0.01%	8140

Other funds holding OKUR

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

ACA

Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return

StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

FCMV

Foresite Capital Management VI Larkspur, California $460M AUM 261.77% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Jane Street's OKUR Position: Q1 2026 in Review

Jane Street increased its OnKure Therapeutics (OKUR) stake by 38% in Q1 2026, buying an estimated $22.8K and bringing the position to 26,812 shares worth $111K. The position accounts for ﹤0.01% of the portfolio, ranked #10586.

Jane Street first reported a position in OKUR in Q1 2023 and has held it in 5 quarters since. The position peaked at $126K in Q4 2023. 51 funds tracked by Wall St. Rank hold OKUR as of Q1 2026.

Jane Street held 26,812 shares of OnKure Therapeutics worth $111K as of Q1 2026.
Jane Street bought 7,398 OnKure Therapeutics shares in Q1 2026, an estimated $22.8K.
OnKure Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #10586 holding.
Jane Street first reported a position in OnKure Therapeutics in Q1 2023 and has held it in 5 quarters since.
Jane Street's OnKure Therapeutics position peaked at $126K in Q4 2023.
51 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.